Clinical Trials Browser

Phase 2 × Rectal Neoplasms × Semaxinib × Clear all

NCT00006001 2013-06-03

SU5416 in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer

Phase 2 Terminated

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms